CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...